Additionally, the influence of the applied combinations on the serum concentration of brain-derived neurotrophic factor (BDNF) whose concentration is modified in the course of depression [33, 34], and on the expression of selected genes involved in neuronal signaling (Adora1, Comt, and Slc6a15) was evaluated. The gene discussed is SLC6A15; the disease is depressive disorder.